http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5feed34b30e9b9d7371c1d69e3eaefaf
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Bergh |
| name | Jonas Bergh |
| given-name | Jonas |
| organization-name | Radiumhemmet, Karolinska Institute and Hospital Department of Oncology-Pathology, Radiumhemmet, Cancer Center Karolinska, Karolinska Institutet and University Hospital, Stockholm, Sweden Breast Cancer Center, Karolinska University Hospital, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden Carolyn Taylor, Frances K. Duane, David Dodwell, Richard Gray, Zhe Wang, Yaochen Wang, Richard Peto, and Paul McGale, University of Oxford, Oxford, United Kingdom; Candace Correa, Regional Cancer Center, Utica, NY; Marianne C. Aznar, Rigshospitalet, Copenhagen; Marianne Ewertz, Odense University Hospital, Odense, Denmark; Stewart J. Anderson, University of Pittsburgh, Pittsburgh, PA; Jonas Bergh, Karolinska Institutet and University Hospital, Stockholm, Sweden; Reshma Jagsi and Lori Pierce, University of... 1Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden. Donald A. Berry, Naoto T. Ueno, Marcella M. Johnson, Xiudong Lei, Jean Caputo, Gabriel N. Hortobagyi, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Sjoerd Rodenhuis, the Netherlands Cancer Institute, Amsterdam, the Netherlands; William P. Peters, Regional Consultants in Hematology Oncology, Amelia Island, FL; Robert C. Leonard, Charing Cross Hospital, London, United Kingdom; William E. Barlow, Southwest Oncology Group Statistical Center, Seattle, WA; Martin S. Tallman, Memorial Sloan... From the University of Washington; Seattle Cancer Care Alliance, Seattle, WA; Clinical Investigations Branch, Division of Cancer Diagnosis and Treatment; Biostatistics Branch, Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, Bethesda; Emmes Corporation, Rockville, MD; Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Karmanos... Antroula Papakonstantinou, Theodoros Foukakis, Kenny A. Rodriguez-Wallberg, and Jonas Bergh, Karolinska Institutet and University Hospital, Stockholm, Sweden Karolinska Institutet Radiumhemmet and Karolinska University Hospital Stockholm Sweden Karolinska Institutet and University Hospital, Stockholm, Sweden Department of Oncology and Pathology Karolinska Institutet Stockholm Sweden; Cancer Center Karolinska Stockholm Sweden; Department of Oncology Karolinska University Hospital Stockholm Sweden Jonas Bergh, Fredrik Wiklund, and Roger Henriksson, Karolinska Institutet; Jonas Bergh, Elisabet Kerstin Lidbrink, and Roger Henriksson, Karolinska University Hospital, Stockholm; Per-Ebbe Jönsson, Helsingborg Hospital, Lund University, Helsingborg; Daniel Brattström, AstraZeneca, Södertälje; Roger Henriksson, University Hospital, Umeå, Sweden; Maureen Trudeau, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Wolfgang Eiermann, Red Cross Clinic, Munich, Germany; Justin P.O. Lindemann,... prof, institutionen för onkologi-patologi, Karolinska institutet, Stockholm. 1Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden.; 5Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden. Department of Oncology‐Pathology Cancer Center Karolinska, Karolinska Institutet Stockholm Sweden; Radiumhemmet, Karolinska University Hospital Stockholm Sweden Department of Oncology‐Pathology, Karolinska Institutet and Breast Cancer Center, Cancer Theme Karolinska University Hospital Stockholm Sweden From the Department of Medical Epidemiology and Biostatistics, Stockholm Söder Hospital and Oncologic Center, Clintec, and Department of Oncology, Radiumhemmet, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; and the Department of Epidemiology, Harvard University, Boston, MA Department of Oncology, University Hospital, Uppsala, Sweden Department of Oncology and Pathology, Radiumhemmet, Karolinska Institute and Hospital 3 3 S-171 76 Stockholm, Sweden Genome Institute of Singapore, 60 Biopolis Street, #02-01, Singapore 138672; Department of Oncology and Pathology, Radiumhemmet, Karolinska Institute and Hospital, S-17176 Stockholm, Sweden; and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden Department of Oncology-Pathology, Karolinska Institutet, Breast Cancer Group and Radiumhemmet, Cancer Theme, Karolinska University Hospital, Stockholm, Sweden From the Swiss Cardiovascular Center, University Hospital Bern; F. Hoffmann-La Roche, Basel, Switzerland; Frontier Science, Kincraig, Kingussie, Scotland; Department of Cardiology, University of Groningen, Groningen; Department of Medical Oncology, Daniel den Hoed Cancer Center/Erasmus MC, Rotterdam, the Netherlands; Kardiologische Praxis, Munich; Cardiology Wilhelm-Marx-Haus and Krankenhaus Gerresheim, Duesseldorf; Department of Cardiology, University Hospital Hamburg-Eppendorf, Germany; Department of... From the Copenhagen University Hospital Rigshospitalet; Danish Breast Cancer Cooperative Group Secretariat, Copenhagen; Vejle Hospital, Vejle; Aarhus University Hospital, Aarhus; Roskilde Hospital, Roskilde, Denmark; Radiumhemmet and Cancer Center Karolinska, Karolinska Institutet and University Hospital, Stockholm; Sahlgrenska University Hospital, Gothenburg, Sweden; Oslo University Hospital, Ullevaal, Norway; and Manchester University/Paterson Institute, Christie Hospital, Manchester, United Kingdom. Departments of Oncology–Pathology and Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden; Breast Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden From the Jules Bordet Institute; Machine Learning Group, Université Libre de Bruxelles; International Drug and Development Institute, Brussels, Belgium; Peter MacCallum Cancer Center, Melbourne, Australia; Guys Hospital, London; John Radcliffe Hospital, Oxford, United Kingdom; Karolinska Institute, Stockholm, Sweden; Erasmus Medical Center, Daniel den Hoed Cancer Center, Rotterdam, the Netherlands; National Center of Competence in Research Molecular Oncology, Swiss Institute of Cancer Research and Swiss... Department of Public Health, Oxford University, Oxford, United Kingdom. Department of Oncology & Pathology, Karolinska Institutet, SE171-76 Stockholm, Sweden; Department of Clinical Oncology, Karolinska University Hospital, SE171-76 Stockholm, Sweden Scientific Advisory Group, European Medicines Agency, Amsterdam, The Netherlands; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital BioClinicum, New Karolinska Hospital, Solna, Sweden Department of Oncology-Pathology, Karolinska Institute and University Hospital, SE-17176 Stockholm, Sweden; Breast Cancer Flow, Patient Area of Breast Cancer Sarcoma and Endocrine Tumours, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden 1Breast Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.; 2Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden. Department of Oncology-Pathology, Karolinska Institutet, Breast, Endocrine and Sarcoma Section, Cancer Theme, Karolinska University Hospital, Stockholm, Sweden From the Department of Oncology, Rigshospitalet, Copenhagen University Hospital; Danish Breast Cancer Cooperative Group Registry, Copenhagen; Department of Oncology, Odense University Hospital, Odense; Department of Oncology, Aalborg Hospital, Aarhus University, Aarhus; Department of Oncology, Herlev University Hospital, Herlev, Denmark; Department of Oncology, Umeaa County Hospital, Umeaa; Radiumhemmet, Stockholm Oncology, Karolinska Institute and University Hospital, Stockholm; Department of Oncology,... 4Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden. Department of Oncology‐Pathology Karolinska University Hospital Stockholm Sweden Radiumhemmet and Karolinska Oncology, Karolinska Institutet & University Hospital, Stockholm, Sweden Department of Oncology‐Pathology, Cancer Center Karolinska, Department of Oncology Radiumhemmet, Karolinska Institutet and Karolinska University Hospital Stockholm 17176 Sweden Department of Oncology-Pathology, Karolinska Institut, Stockholm, Sweden; Christian Dittrich, Kaiser Franz Josef-Spital, and Applied Cancer Research–Institution for Translational Research, Vienna, Austria; Michael P. Kosty, Scripps Clinic, La Jolla, CA; Svetlana Jezdic, European Society for Medical Oncology, Lugano, Switzerland; Doug Pyle, American Society of Clinical Oncology, Alexandria, VA; Rossana Berardi, Azienda Ospedaliero-Universitaria Ospedali Riuniti Università Politecnica delle Marche, Ancona, Italy; Jonas Bergh, Radiumhemmet, Karolinska Institutet and University... 3Radiumhemmet, Department of Oncology and Pathology, Karolinska Institute and University Hospital, Stockholm, Sweden Karolinska institutet och Karolinska universitetssjukhuset, Solna. jonas.bergh@ki.se Department of Oncology/Radiumhemmet, Karolinska Oncology, Karolinska Institutet and University Hospital, Stockholm, Sweden. 8Cancer Centre Karolinska and Radiumhemmet, Karolinska Institute and University Hospital, Stockholm, Sweden European Medicines Agency, London, United Kingdom; Karolinska Institutet and University Hospital, Radumhemmet, Karolinska Oncology, Stockholm, Sweden Department of Oncology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden Oncology, Akademiska University Hospital, S-751 85 Uppsala, Sweden From the Centre Oscar Lambret, Lille; Centre Georges-François Leclerc, Dijon; and Centre Eugène Marquis, Rennes, France; Karolinska Hospital, Stockholm; University Hospital, Uppsala, Sweden; Institute of Cancer Research, Sutton; Cancer Research United Kingdom Laboratories, Imperial College, London, United Kingdom; Institut Jules Bordet and European Organisation for Research and Treatment of Cancer Data Center, Brussels, Belgium; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario... European Medicines Agency, London, United Kingdom; Karolinska Institutet, Stockholm, Sweden Karolinska Institutet, Stockholm, Sweden; Authors' Affiliations: Department of 1Bioinformatics; 2Biostatistics; 3Experimental Therapeutics, and 4Radiation Oncology, H Lee Moffitt Cancer Center, Tampa, Florida; 5Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 6Department of Medical Oncology and Cancer Genomics, Erasmus Medical Center Rotterdam, Rotterdam, Netherlands; 7Ponce School of Medicine, Ponce, Puerto Rico; and 8Department of Oncology, Radiumhemmet, Karolinska Institutet and University Hospital, Stockholm, Sweden 3Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; 7Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden. Department of Oncology-Pathology, Cancer Research Karolinska Institutet, Stockholm Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet and University Hospital, Stockholm, Sweden 2Department of Oncology-Pathology, Radiumhemmet, Karolinska Institutet and Karolinska University Hospital, Cancer Centre Karolinska, Stockholm, Sweden. Department of Oncology and Pathology, Karolinska Institutet and Karolinska University Hospital, Sweden 8Karolinska Institute, Stockholm, Sweden; Linda Sofie Lindström, Eva Karlsson, Ulla M. Wilking, Johan Hartman, Elisabet Kerstin Lidbrink, Thomas Hatschek, Lambert Skoog, and Jonas Bergh, Cancer Center Karolinska, Radiumhemmet, Karolinska Institutet and Karolinska University Hospital; Ulla Johansson, Oncologic Center, Karolinska Institutet, Stockholm; Eva Karlsson, Karlstad Hospital, Karlstad, Sweden; Jonas Bergh, The Christie Hospital, Manchester University, and Paterson Institute, Manchester, United Kingdom; Linda Sofie Lindström, Department of... Department of Oncology-Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden Department of Clinical Oncology, Karolinska University Hospital, SE171-76 Stockholm, Sweden; Department of Oncology & Pathology, Karolinska institutet, SE171-76 Stockholm, Sweden IARC, Lyon, France. Cancer Centre Karolinska, Radiumhemmet, Karolinska Institute & Hospital, SE-171 76 Stockholm, Sweden Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;; Breast Cancer, Endocrine Tumours and Sarcoma Section, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; Oncology/Pathology Department Karolinska Institutet Stockholm Sweden; Breast Center, Karolinska Comprehensive Cancer Center and Karolinska University Hospital Stockholm Sweden Department of Oncology and Pathology Karolinska Institutet Stockholm Sweden; Radiumhemmet Karolinska Oncology Karolinska University Hospital Stockholm Sweden Department of Oncology-Pathology, Karolinska Institutet; Breast Cancer Center, Karolinska University Hospital; Karolinska Comprehensive Cancer Center Authors' Affiliations: Departments of 1Cancer Biology, 2Biostatistical Sciences, and 3Biochemistry, and 4The Comprehensive Cancer Center of Wake Forest University, Wake Forest School of Medicine, Winston-Salem, North Carolina; 5Department of Biochemistry, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand; and 6Department of Oncology and Pathology, Cancer Centrum Karolinska, Radiumhemmet, Karolinska Institutet and Hospital, Stockholm, Sweden and Manchester University, Manchester, United Kingdom Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden Ludwig Institute for Cancer Research, Uppsala Branch, Department of Lung Medicine and Department of Oncology and Pathology, University Hospital, Uppsala, Sweden Manchester University, Christie Hospital, Manchester, England. jonas.bergh@ki.se Department of Oncology, Karolinska Institutet, Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden Department of Pathology, Department of Pediatric Surgery, and Department of Lung Medicine, University of Uppsala, Uppsala, Sweden Karolinska Institutet, Stockholm, Sweden 6Department of Oncology and Pathology, Radiumhemmet, Karolinska Institute and Hospital; 5Department of Oncology and Pathology, Radiumhemmet, Karolinska Institute and Hospital, Stockholm, Sweden Jonas Bergh and Annelie Liljegren, Karolinska Institutet and University Hospital, Stockholm, Sweden; Jonas Bergh, University of Manchester, Paterson Institute for Cancer Research, Manchester, United Kingdom; Igor M. Bondarenko, Dnipropetrovsk City Multiple-Discipline Clinical Hospital No. 4, Dnipropetrovsk; Nataliya L. Voytko, Kyiv City Oncologic Hospital, Kyiv, Ukraine; Mikhail R. Lichinitser, National Cancer Research Center; Anatoly N. Makhson, City Oncology Clinical Hospital No. 62, Moscow, Russian... Department of Oncology Karolinska University Hospital Stockholm Sweden; Department of Oncology‐Pathology Radiumhemmet, Karolinska Institutet Stockholm Sweden Department of Oncology-Pathology, Karolinska Institutet, 17165 Solna, Sweden; 4Department of Oncology and Pathology, Karolinska Institutet, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden.; 9Department of Public Health, Oxford University, Oxford, United Kingdom. Department of Oncology-Pathology Karolinska Institute and University Hospital Stockholm Sweden Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Solna, Sweden; Breast Cancer Theme Center, Karolinska University Hospital and Karolinska Comprehensive Cancer Centre, Stockholm, Sweden From the Odette Cancer Center, McMaster University, Hamilton, ON, Karolinska Institutet, Stockholm, Sweden, and the Dana-Farber Cancer Institute, Boston, MA. Department of Oncology, Karolinska Institutet and University Hospital, Stockholm, Sweden Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska University Hospital-Solna, S-171 76 Stockholm, Sweden Department of Oncology-Pathology, Karolinska Institutet, Stockholm 17164, Sweden; Breast Center, Theme Cancer, Karolinska University Hospital, Stockholm 17176, Sweden Karolinska Institute and Hospital, Stockholm, Sweden Department of Oncology-Pathology, Karolinska Institutet, BES, Cancer Theme, Karolinska University Hospital Bioclinicum, Solna, Sweden Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Breast Cancer Flow, Patient Area of Breast Cancer Sarcoma and Endocrine Tumours, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden Department of Oncology‐Pathology Karolinska Institute Stockholm Sweden; Breast Center Theme Cancer Karolinska University Hospital Stockholm Sweden |
Incoming Links
Total number of triples: 414.